Gates Package — page 214
of 1375 pages
← p.213 p.215 → · this page in the original PDF · package
G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023
Reference# I Agreement Type
Effective Date Expiration Da External Parties
*Lead Pl
GlaxoSmithKline Biologicals SA (GSK Biologicals,
2017-0034
CRADA
2/8/2019]
12/31/2023] GSK) [BE]
Jeffrey Cohen
2017-0041
Gift
3/27/2017)
5/31/2018] Boston Children's Hospital, March of Dimes
Luigi Notarangelo
Foundation for the National Institutes of Health,
2017-0057
Gift
4/26/2017|
10/31/2022 }Inc. (FNIH)
Clifton Barry
Bill & Melinda Gates Foundation (BMGF),
Foundation for the National Institutes of Health,
2017-0057
Gift
4/26/2017)
10/31/2022|Inc. (FNIH)
Clifton Barry
2017-0087
Research Collaboration Agreement
8/15/2017]
9/19/2024} Codagenix Inc.
Peter Collins
2017-0087
Research Collaboration Agreement
8/15/2017]
9/19/2024|Codagenix Inc.
Ursula Buchholz
2017-0087
Research Collaboration Agreement
8/15/2017]
9/19/2024} Codagenix Inc.
Ursula Buchholz
2017-0087
Research Collaboration Agreement
8/15/2017|
_9/19/2024|Codagenix Inc.
Peter Collins
2017-0087
Research Collaboration Agreement
8/15/2017]
9/19/2024} Codagenix Inc.
Peter Collins
2017-0087
Research Collaboration Agreement
8/15/2017]
9/19/2024] Codagenix Inc.
Ursula Buchholz
2017-0087
Research Collaboration Agreement
8/15/2017]
9/19/2024} Codagenix Inc.
Ursula Buchholz
Veterans Administration San Diego Healthcare
2017-0093
Research Collaboration Agreement
5/11/2017]
5/11/2022|System (VA)
Veterans Administration San Diego Healthcare
2017-0093
Research Collaboration Agreement
5/11/2017]
5/11/2022}System (VA)
Bill
& Melinda Gates Foundation (BMGF),
Foundation for the National Institutes of Health,
2017-0094
Gift
5/12/2017}
12/31/2020} Inc. (FNIH)
Clifton Barry
Foundation for the National Institutes of Health,
2017-0094
Gift
5/12/2017}
12/31/2020] Inc. (FNIH)
Clifton Barry
2017-0102
Research Collaboration Agreement
12/3/2017|
12/3/2020|Janus-I Science Inc.
Jeffery Taubenber
2017-0102
Research Collaboration Agreement
12/3/2017]
12/3/2020|Janus-I Science Inc.
Jeffery Taubenber
2017-0102
Research Collaboration Agreement
12/3/2017|
12/3/2020|Janus-I Science Inc.
Jeffery Taubenber
GlaxoSmithKline Biologicals SA (GSK Biologicals,
GSK) [BE], PATH Malaria Vaccine Initiative (MVI)
2017-0108
Research Collaboration Agreement
9/28/2017}
_9/28/2020}[Us]
Patrick Duffy
2017-0112
CTA - Clinical Trial Agreement
4/25/2017)
4/25/2020]Sanaria, Inc. (see also Protein Potential)
Patrick Duffy
2017-0114
Research Collaboration Agreement
4/27/2017)
4/27/2020|PATH Malaria Vaccine Initiative (MVI) [US]
Patrick Duffy
2017-0115
Research Collaboration Agreement
2/21/2018]
_2/21/2020|Mymetics Corporation [CH]
Patrick Duffy
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/gates/214
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| gates:exh:00107 | — | attachment | 214 |